Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Curcumin and piperine may effectively and safely promote hair regrowth in alopecia.

SCLL improves finasteride delivery for better hair growth in treating hair loss.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Different scalp imaging methods are important for studying hair and scalp health and require more volunteers for better evaluation.

New drug delivery systems show promise for better alopecia treatment but need more safety tests and standardization.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

New treatments targeting specific genes show promise for treating keratin disorders.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.